A Phase II Trial Investigating Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia

Trial Profile

A Phase II Trial Investigating Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 25 Apr 2016

At a glance

  • Drugs Clofarabine (Primary) ; Cyclophosphamide; Etoposide
  • Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Apr 2016 Status changed from recruiting to withdrawn prior to enrolment.
    • 01 Dec 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 24 May 2013 Planned initiation date changed from 1 Dec 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top